← All candidates
30 insider filings on record.
30 filings on record.
COGTCogent Biosciences, Inc.
NasdaqGS · Healthcare · $5.65B
$32.54
-0.61% · Sep 16
30 insider filings on record.
None of them an open-market buy in the last year.
Price · 1Y · daily● 7 sells◆ 4 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
Reverse-split 1×. When a company does a reverse split, the chart rewrites its old prices to look far bigger than they really were — so the high early prices here aren't what COGT ever actually traded at. The drop is real, but those huge old numbers aren't.
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$5.65B
Float
172.6M
99% public
Short % float
Pro
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Fairmount Funds Management LLC
Bought $25.00M on Jul 10 — 2,777,777 sh @ $9.00, held indirect, 31% of their stake.
2 of 4 positions beat the S&P
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
25 more transactions on Pro →Context
Wall St
$54.25 avg target
+66.7% vs today · 12 analysts
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
3 of 4 quarters beat
Q1 '26−$0.53 act+$0.01
Q4 '25−$0.56 act−$0.05
Q3 '25−$0.50 act+$0.02
Q2 '25−$0.53 act+$0.05
Coverage
Is Cogent Biosciences (COGT) ’s New Cancer Drug 100 Times More Precise Than What’s Already on the Market?Insider Monkey · 06-22Cogent Biosciences' Potential Rare Blood Disease Treatment Meets Endpoints in Clinical TrialMT Newswires · 06-12How Investors May Respond To Cogent Biosciences (COGT) Priority Review For Bezuclastinib GIST RegimenSimply Wall St. · 06-10Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now?Insider Monkey · 06-07
The file stays open
30 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice